What type of study is this?

September 5, 2025CureusOpen Access

Beyond Mean Absolute Relative Difference (MARD): Rethinking Continuous Glucose Monitoring (CGM) Evaluation for Real-World Diabetes Care

View Full Paper

Ask AI

Bookmark

A four-dimensional evaluation framework improves continuous glucose monitoring accuracy and safety.
Current reliance on mean absolute relative difference (MARD) inadequately reflects real-world sensor performance.
Automated insulin delivery systems depend on accurate continuous glucose monitoring for minimizing hypoglycemia risks.
Addressing diverse contexts of CGM device use is essential for effective diabetes management and patient care.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

This editorial proposes a four-dimensional framework for evaluating continuous glucose monitoring, emphasizing patient safety and real-world performance.

Cite This Study

Acanfora et al. (2025) studied this question.

synapsesocial.com/papers/68bb5f586d6d5674bcd036c3 https://doi.org/10.7759/cureus.91427

View Full Paper

Ask AI

Bookmark

Implication

This editorial proposes a four-dimensional framework for evaluating continuous glucose monitoring, emphasizing patient safety and real-world performance.

Beyond Mean Absolute Relative Difference (MARD): Rethinking Continuous Glucose Monitoring (CGM) Evaluation for Real-World Diabetes Care

Key Points

Discussion

Implication

Cite This Study

Beyond Mean Absolute Relative Difference (MARD): Rethinking Continuous Glucose Monitoring (CGM) Evaluation for Real-World Diabetes Care

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider